Recruiting at 7 sites No phase Gastro-esophageal Reflux Disease

Clinical trial for Gastro-esophageal Reflux Disease

Official title Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy

ClinicalTrials.gov ID: NCT03596476

What this study is testing

What it's testing
The study wants to find out if this short test can accurately detect reflux in patients who still have GERD symptoms while on PPIs.
Who it's for
Adults who have ongoing heartburn, regurgitation, or related symptoms despite taking proton pump inhibitor medication.
What's involved
Participants will have a catheter placed in the esophagus to measure pressure and liquid/gas flow for about one hour after eating, along with any required study visits.
Time commitment
A single study visit lasting roughly one hour for the test, plus any brief follow‑up appointments.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Patient older than 18 years
  • Typical symptoms of GERD (heartburn, regurgitation) at least twice a week despite PPI therapy for at least one month.
  • Reflux Disease Questionnaire (RDQ) score off PPI \> 3
  • Subject with health insurance

You likely can't join if

  • Previous esophago-gastric surgery,
  • Previous history of developing esophageal or gastric tumor, esophageal stricture, or esophageal varices
  • Pregnancy (assessment at V0)
  • Contraindication to general anesthesia,
  • Contraindications to the wireless capsule pH-monitoring: pacemakers, implantable cardiac defibrillator,
  • Contraindications to HRIM: inability to tolerate nasal intubation, significant bleeding disorders for which nasal intubation is contraindicated...
See the full eligibility criteria
Who can join
  • Patient older than 18 years
  • Typical symptoms of GERD (heartburn, regurgitation) at least twice a week despite PPI therapy for at least one month.
  • Reflux Disease Questionnaire (RDQ) score off PPI \> 3
  • Subject with health insurance
What rules you out
  • Previous esophago-gastric surgery,
  • Previous history of developing esophageal or gastric tumor, esophageal stricture, or esophageal varices
  • Pregnancy (assessment at V0)
  • Contraindication to general anesthesia,
  • Contraindications to the wireless capsule pH-monitoring: pacemakers, implantable cardiac defibrillator,
  • Contraindications to HRIM: inability to tolerate nasal intubation, significant bleeding disorders for which nasal intubation is contraindicated, known esophageal obstruction is preventing the passage of the HRIM probe.
  • Intolerance or allergy to one component of the test meal,
  • Intolerance or allergy to PPI,
  • Inability to give consent,
  • Mentally unbalanced patients, under supervision or guardianship
  • Decline to participate in the study,
  • Participation in another study at the same time

The study team makes the final eligibility decision.

Where it is enrolling

  • Chambray-lès-Tours, France
  • Colombes, France
  • Lyon, France
  • Nantes, France
  • Pessac, France
  • Rennes, France
  • Rouen, France

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Chambray-lès-Tours, France; Colombes, France; Lyon, France; Nantes, France; Pessac, France; Rennes, France and 1 more location. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.